Glen Santangelo
Stock Analyst at Barclays
(2.33)
# 2,727
Out of 5,182 analysts
138
Total ratings
44.68%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $30 → $23 | $20.37 | +12.91% | 4 | Apr 8, 2026 | |
| PHAT Phathom Pharmaceuticals | Upgrades: Overweight | $16 → $18 | $12.63 | +42.52% | 3 | Mar 27, 2026 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $8.5 → $7 | $5.10 | +37.25% | 9 | Mar 26, 2026 | |
| PCRX Pacira BioSciences | Maintains: Equal-Weight | $27 → $25 | $23.79 | +5.09% | 7 | Mar 26, 2026 | |
| VTRS Viatris | Maintains: Overweight | $15 → $17 | $13.47 | +26.21% | 6 | Mar 24, 2026 | |
| ALVO Alvotech | Maintains: Underweight | $5 → $4 | $3.62 | +10.50% | 2 | Mar 24, 2026 | |
| PGNY Progyny | Maintains: Overweight | $29 → $23 | $16.30 | +41.10% | 6 | Mar 20, 2026 | |
| ALGN Align Technology | Upgrades: Overweight | $200 | $173.14 | +15.51% | 4 | Mar 17, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $25 → $29 | $19.43 | +49.25% | 7 | Mar 11, 2026 | |
| TALK Talkspace | Maintains: Equal-Weight | $5.5 → $5.25 | $5.17 | +1.55% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $7 | $5.60 | +25.00% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7.5 → $8 | $8.83 | -9.40% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $258 | $215.52 | +19.71% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $960 → $1,050 | $865.60 | +21.30% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $110 | $77.96 | +41.10% | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $425 | $320.82 | +32.47% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $34 | $26.39 | +28.84% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $38 | $21.05 | +80.52% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $563.00 | +42.10% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $30.82 | +23.30% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.19 | +25.57% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $45.60 | +9.65% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $35.47 | +57.88% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $8.06 | +197.77% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $117.86 | +15.39% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $5.85 | +53.85% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $72.56 | +37.82% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $75.34 | +14.15% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $23.13 | +29.70% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.71 | +2.48% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $78.36 | +27.62% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.54 | +19.62% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $35.22 | +39.13% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $21.50 | +137.21% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $5.11 | +1,856.95% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $75.80 | -27.44% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.60 | +681.25% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.00 | +2,710.40% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $5.19 | +2,212.14% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.95 | +3,703.49% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $79.33 | - | 3 | Mar 17, 2021 |
Amphastar Pharmaceuticals
Apr 8, 2026
Maintains: Equal-Weight
Price Target: $30 → $23
Current: $20.37
Upside: +12.91%
Phathom Pharmaceuticals
Mar 27, 2026
Upgrades: Overweight
Price Target: $16 → $18
Current: $12.63
Upside: +42.52%
Teladoc Health
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $8.5 → $7
Current: $5.10
Upside: +37.25%
Pacira BioSciences
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $27 → $25
Current: $23.79
Upside: +5.09%
Viatris
Mar 24, 2026
Maintains: Overweight
Price Target: $15 → $17
Current: $13.47
Upside: +26.21%
Alvotech
Mar 24, 2026
Maintains: Underweight
Price Target: $5 → $4
Current: $3.62
Upside: +10.50%
Progyny
Mar 20, 2026
Maintains: Overweight
Price Target: $29 → $23
Current: $16.30
Upside: +41.10%
Align Technology
Mar 17, 2026
Upgrades: Overweight
Price Target: $200
Current: $173.14
Upside: +15.51%
Hims & Hers Health
Mar 11, 2026
Maintains: Overweight
Price Target: $25 → $29
Current: $19.43
Upside: +49.25%
Talkspace
Mar 10, 2026
Maintains: Equal-Weight
Price Target: $5.5 → $5.25
Current: $5.17
Upside: +1.55%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.60
Upside: +25.00%
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $8.83
Upside: -9.40%
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $215.52
Upside: +19.71%
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $865.60
Upside: +21.30%
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $77.96
Upside: +41.10%
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $320.82
Upside: +32.47%
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $26.39
Upside: +28.84%
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $21.05
Upside: +80.52%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $563.00
Upside: +42.10%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $30.82
Upside: +23.30%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.19
Upside: +25.57%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $45.60
Upside: +9.65%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $35.47
Upside: +57.88%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $8.06
Upside: +197.77%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $117.86
Upside: +15.39%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $5.85
Upside: +53.85%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $72.56
Upside: +37.82%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $75.34
Upside: +14.15%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $23.13
Upside: +29.70%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.71
Upside: +2.48%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $78.36
Upside: +27.62%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.54
Upside: +19.62%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $35.22
Upside: +39.13%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $21.50
Upside: +137.21%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $5.11
Upside: +1,856.95%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $75.80
Upside: -27.44%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.60
Upside: +681.25%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.00
Upside: +2,710.40%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $5.19
Upside: +2,212.14%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $0.95
Upside: +3,703.49%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $79.33
Upside: -